Role of HIV-specific CD8+ T cells in pediatric HIV cure strategies after widespread early viral escape

Recent studies have suggested greater HIV cure potential among infected children than adults. A major obstacle to HIV eradication in adults is that the viral reservoir is largely comprised of HIV-specific cytotoxic T lymphocyte (CTL) escape variants. We here evaluate the potential for CTL in HIV-infected slow-progressor children to play an effective role in “shock-and-kill” cure strategies. Two distinct subgroups of children were identified on the basis of viral load. Unexpectedly, in both groups, as in adults, HIV-specific CTL drove the selection of escape variants across a range of epitopes within the first weeks of infection. However, in HIV-infected children, but not adults, de novo autologous variant-specific CTL responses were generated, enabling the pediatric immune system to “corner” the virus. Thus, even when escape variants are selected in early infection, the capacity in children to generate variant-specific anti-HIV CTL responses maintains the potential for CTL to contribute to effective shock-and-kill cure strategies in pediatric HIV infection.

[1]  J. Church Nonprogressing HIV-Infected Children Share Fundamental Immunological Features of Nonpathogenic SIV Infection , 2017, Pediatrics.

[2]  B. Walker,et al.  Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection , 2016, Science Translational Medicine.

[3]  T. Ndung’u,et al.  Paediatric non-progression following grandmother-to-child HIV transmission , 2016, Retrovirology.

[4]  A. Folgori,et al.  Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection , 2016, Vaccines.

[5]  Barton F. Haynes,et al.  Latency reversal and viral clearance to cure HIV-1 , 2016, Science.

[6]  B. Walker,et al.  Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable , 2016, Nature Communications.

[7]  Charles E. DeZiel,et al.  Impact of Pre-adapted HIV Transmission , 2016, Nature Medicine.

[8]  A. McMichael,et al.  Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  S. Lewin,et al.  Paediatric HIV infection: the potential for cure , 2016, Nature Reviews Immunology.

[10]  B. Walker,et al.  Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02 , 2016, Journal of Infectious Diseases.

[11]  R. Siliciano,et al.  HIV-specific CD8⁺ T cells and HIV eradication. , 2016, The Journal of clinical investigation.

[12]  C. Rouzioux,et al.  HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. , 2016, The lancet. HIV.

[13]  M. Carrington,et al.  Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection , 2015, PLoS pathogens.

[14]  Astrid Gall,et al.  IVA: accurate de novo assembly of RNA virus genomes , 2015, Bioinform..

[15]  R. Siliciano,et al.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.

[16]  Angela R. McLean,et al.  Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence , 2014, Proceedings of the National Academy of Sciences.

[17]  P. Klenerman,et al.  Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load , 2014, AIDS.

[18]  T. Hanke,et al.  Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial , 2014, PloS one.

[19]  B. Walker,et al.  HIV subtype influences HLA-B*07:02-associated HIV disease outcome. , 2014, AIDS research and human retroviruses.

[20]  P. Kellam,et al.  Complete Genome Sequence of the WHO International Standard for HIV-1 RNA Determined by Deep Sequencing , 2014, Genome Announcements.

[21]  Jessica Prince,et al.  Selection bias at the heterosexual HIV-1 transmission bottleneck , 2013, Science.

[22]  Gabor T. Marth,et al.  MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping , 2013, PloS one.

[23]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[24]  D. Richman,et al.  Absence of detectable HIV-1 viremia after treatment cessation in an infant. , 2013, The New England journal of medicine.

[25]  N. Frahm,et al.  Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. , 2013, The Journal of infectious diseases.

[26]  B. Walker,et al.  HLA-A*68: 02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective , 2013, AIDS.

[27]  B. Angus,et al.  Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection. , 2013, Journal of immunological methods.

[28]  Brigitte Autran,et al.  Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.

[29]  Andrew L. Ferguson,et al.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. , 2013, Immunity.

[30]  David Heckerman,et al.  Frequent and Variable Cytotoxic-T-Lymphocyte Escape-Associated Fitness Costs in the Human Immunodeficiency Virus Type 1 Subtype B Gag Proteins , 2013, Journal of Virology.

[31]  Feng Gao,et al.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. , 2012, The Journal of clinical investigation.

[32]  Anuska Llano,et al.  Best-Characterized HIV-1 CTL Epitopes: The 2013 Update , 2013 .

[33]  B. Walker,et al.  HIV and HLA class I: an evolving relationship. , 2012, Immunity.

[34]  Astrid Gall,et al.  Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes , 2012, Journal of Clinical Microbiology.

[35]  Andrew K. Sewell,et al.  Differential Clade-Specific HLA-B*3501 Association with HIV-1 Disease Outcome Is Linked to Immunogenicity of a Single Gag Epitope , 2012, Journal of Virology.

[36]  B. Walker,et al.  HIV control through a single nucleotide on the HLA-I locus , 2012, Retrovirology.

[37]  S. Deeks HIV: Shock and kill , 2012, Nature.

[38]  Huldrych F. Günthard,et al.  Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.

[39]  David Heckerman,et al.  Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.

[40]  Zabrina L. Brumme,et al.  Impact of HLA-B*81-Associated Mutations in HIV-1 Gag on Viral Replication Capacity , 2012, Journal of Virology.

[41]  Michael A Quail,et al.  Optimal enzymes for amplifying sequencing libraries , 2011, Nature Methods.

[42]  B. Walker,et al.  HLA-B*57 Micropolymorphism Shapes HLA Allele-Specific Epitope Immunogenicity, Selection Pressure, and HIV Immune Control , 2011, Journal of Virology.

[43]  J. Brenchley,et al.  Low levels of SIV infection in sooty mangabey central-memory CD4+ T-cells is associated with limited CCR5 expression , 2011, Nature Medicine.

[44]  D. Heckerman,et al.  HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 , 2011, The Journal of Immunology.

[45]  J. Kappes,et al.  An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum , 2011, Journal of Virology.

[46]  David Heckerman,et al.  Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.

[47]  S. Buus,et al.  Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.

[48]  P. Goulder,et al.  Long-Term Control of HIV-1 in Hemophiliacs Carrying Slow-Progressing Allele HLA-B*5101 , 2010, Journal of Virology.

[49]  Bette Korber,et al.  Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys , 2010, Nature Medicine.

[50]  B. Walker,et al.  Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection , 2009, Journal of Virology.

[51]  B. Autran,et al.  Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. , 2009, Blood.

[52]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[53]  Todd M. Allen,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition , 2009, Journal of Virology.

[54]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[55]  Eric J. Arts,et al.  Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.

[56]  Paediatric European Network for Treatment of AIDS , 2009 .

[57]  Bin Li,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.

[58]  Richard Durbin,et al.  A large genome center's improvements to the Illumina sequencing system , 2008, Nature Methods.

[59]  A. d’Arminio Monforte,et al.  Response to combination antiretroviral therapy: variation by age , 2008, AIDS.

[60]  B. Walker,et al.  Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants , 2008, AIDS.

[61]  David Heckerman,et al.  Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.

[62]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[63]  David Heckerman,et al.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.

[64]  Todd M. Allen,et al.  Crippling HIV one mutation at a time , 2008, The Journal of experimental medicine.

[65]  D. Heckerman,et al.  Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. , 2008, AIDS research and human retroviruses.

[66]  N. Jones,et al.  Profile of T cell immune responses in HIV-infected children from Uganda. , 2007, The Journal of infectious diseases.

[67]  David A. Price,et al.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.

[68]  B. Walker,et al.  Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants , 2007, Journal of Virology.

[69]  D. Watkins,et al.  Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation , 2007, Journal of Virology.

[70]  B. Walker,et al.  High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis , 2007, AIDS.

[71]  E. Rosenberg,et al.  Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.

[72]  D. Watkins,et al.  Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.

[73]  David Heckerman,et al.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.

[74]  James Theiler,et al.  Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants , 2007, Nature Medicine.

[75]  M. Hoelscher,et al.  CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients , 2006, Journal of Virology.

[76]  B. Walker,et al.  Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype , 2006, The Journal of Immunology.

[77]  Todd M. Allen,et al.  Hitting HIV where it hurts: an alternative approach to HIV vaccine design. , 2006, Trends in immunology.

[78]  Todd M. Allen,et al.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.

[79]  B. Walker,et al.  Motif Inference Reveals Optimal CTL Epitopes Presented by HLA Class I Alleles Highly Prevalent in Southern Africa1 , 2006, The Journal of Immunology.

[80]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[81]  Bette T. Korber,et al.  Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control , 2006, Journal of Virology.

[82]  K. Luzuriaga,et al.  HIV-1-Specific CD8+ T Cell Responses and Viral Evolution in Women and Infants1 , 2005, The Journal of Immunology.

[83]  Galit Alter,et al.  De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.

[84]  C. Rouzioux,et al.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  Tulio de Oliveira,et al.  An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..

[86]  E. Holmes,et al.  Unique Acquisition of Cytotoxic T-Lymphocyte Escape Mutants in Infant Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.

[87]  Philip J. R. Goulder,et al.  HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1 , 2005, The Journal of Immunology.

[88]  E. Handelsman,et al.  Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. , 2005, The Journal of allergy and clinical immunology.

[89]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[90]  A. Walker,et al.  Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study , 2004, AIDS.

[91]  D. Katzenstein,et al.  Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load , 2004, Journal of Virology.

[92]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[93]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[94]  E. Ulvestad,et al.  Population-Based Hematologic and Immunologic Reference Values for a Healthy Ugandan Population , 2004, Clinical Diagnostic Laboratory Immunology.

[95]  B. Walker,et al.  Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 Infection 1 , 2003, The Journal of Immunology.

[96]  R. Koup,et al.  T cell dynamics in HIV-1 infection. , 2003, Annual review of immunology.

[97]  R. Gelman,et al.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. , 2003, The Journal of allergy and clinical immunology.

[98]  Kristin Beaudry,et al.  Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys , 2003, Journal of Virology.

[99]  Tao Dong,et al.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.

[100]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[101]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[102]  T. Ndung’u,et al.  Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection , 2003, Journal of Virology.

[103]  Søren Brunak,et al.  Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.

[104]  M. Mulligan,et al.  Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.

[105]  Steven M. Wolinsky,et al.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.

[106]  R. Yogev,et al.  Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants1 , 2001, The Journal of Immunology.

[107]  Todd M. Allen,et al.  Understanding cytotoxic T‐lymphocyte escape during simian immunodeficiency virus infection , 2001, Immunological reviews.

[108]  Michael Bunce,et al.  Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.

[109]  E. Rosenberg,et al.  Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.

[110]  E. Rosenberg,et al.  Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.

[111]  E. Rosenberg,et al.  Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children , 2000, Journal of Virology.

[112]  N. Klein,et al.  Immune repopulation after HAART in previously untreated HIV-1-infected children , 2000, The Lancet.

[113]  Hiv Survival,et al.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.

[114]  M. Leal,et al.  CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients , 2000, Clinical and experimental immunology.

[115]  B. Walker,et al.  The great escape – AIDS viruses and immune control , 1999, Nature Medicine.

[116]  F. Roudot-thoraval,et al.  Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection. , 1999, The Journal of infectious diseases.

[117]  F. Miedema,et al.  T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.

[118]  Rolf M. Zinkernagel,et al.  Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes , 1998, Nature.

[119]  L. Montagnier,et al.  Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease , 1998, Journal of Virology.

[120]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[121]  R. Phillips,et al.  Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. , 1997, AIDS.

[122]  C. Rouzioux,et al.  Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[123]  P. Sansonetti,et al.  Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. , 1995, AIDS research and human retroviruses.

[124]  H. Schuitemaker,et al.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.

[125]  J. Sullivan,et al.  HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. , 1995, Journal of immunology.

[126]  E. Abrams,et al.  Paediatric HIV infection. , 1991, Bailliere's clinical haematology.